Novo Nordisk’s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure
A widely prescribed diabetes drug that has shown potential for helping weakened hearts failed to reduce deaths or rehospitalizations in a study of patients with advanced heart failure.
There was a trend toward worse outcomes among the heart-failure patients who also had diabetes, but this could have occurred by chance.
The clinical trial of 300 patients, published Tuesday in the Journal of the American Medical Association, was led by the University of Pennsylvania and involved 24 U.S. centers, including Thomas Jefferson University Hospital, Temple University Hospital, and Lancaster Heart and Stroke Foundation.
To view the full story, please read at The Philadelphia Inquirer: